659730-27-5

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
7-Hydroxyquinoline-3-carboxylic acid serves as an essential intermediate in the synthesis of various pharmaceuticals and agrochemicals, leveraging its unique chemical properties to enhance the development of new drugs and pesticides.
Used in Antimicrobial Applications:
As an antimicrobial agent, 7-hydroxyquinoline-3-carboxylic acid is utilized for its ability to inhibit the growth of microorganisms, making it a valuable component in the development of antibiotics and antifungal medications.
Used in Anticancer Research:
7-Hydroxyquinoline-3-carboxylic acid is explored as an anticancer agent due to its potential to target and inhibit the growth of cancer cells, offering a promising avenue for cancer treatment and therapy.
Used in Treatment of Infectious Diseases:
7-hydroxyquinoline-3-carboxylic acid has been studied for its potential use in the treatment of tuberculosis and other infectious diseases, highlighting its broad-spectrum activity against various pathogens.
Used as a Corrosion Inhibitor:
7-Hydroxyquinoline-3-carboxylic acid is investigated for its effectiveness as a corrosion inhibitor, providing protection for metals in various industrial applications and extending the lifespan of materials exposed to corrosive environments.
Used as a Chelating Agent in Coordination Chemistry:
7-hydroxyquinoline-3-carboxylic acid's ability to form stable complexes with metal ions makes it a candidate for use as a chelating agent in coordination chemistry, facilitating the synthesis of new coordination compounds with potential applications in various fields.

Upstream product

• 71082-46-7 ethyl 7-methoxy quinoline-3-carboxylate 
• 77156-85-5 Ethyl 4-chloro-7-methoxyquinoline-3-carboxylate 
• 56881-19-7 Diethyl 2-<(3-methoxyphenylamino)methylene>malonate 
• 536-90-3 m-Anisidine 
• 63463-15-0 ethyl 4-hydroxy-7-methoxyquinoline-3-carboxylate 
• 71083-49-3 7-methoxyquinoline-3-carbonitrile 

Relevant academic research and scientific papers

SUBSTITUTED NAPHTHYRIDINE AND QUINOLINE COMPOUNDS AS MAO INHIBITORS

The invention provides a chemical entity of Formula (I) wherein R1, R2, R3, Y, and n have any of the values described herein and compositions comprising such chemical entities; methods of making them; and their use in a wi

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

This invention provides compounds of formula (I): wherein R1a, R1, R2a, and R2b have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.

Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy

This work deals with the design of a "bio-oxidisable prodrug" strategy for the development of new central selective acetylcholinesterase inhibitors. This prodrug approach is expected to reduce peripheral anticholinesterase activity responsible for various

NEW HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-ALZHEIMER AGENTS

The invention is related to compound which comprises at least one radical C=Y, Y being O or S, and an oxidable and non protonable nitrogen atom N wherein the distance (d) between the at least one carbon atom of the radical group C=Y and the nitrogen atom, when oxidized, is comprised between 0.3 and 0.8 nanometers. The invention is related to new heterocyclic compounds defined by formula G, their preparation, to pharmaceutical compositions comprising them and to their use as therapeutic agents, particularly in the treatment of neurodegenerative or Alzheimer disease.